The invention relates to glycopeptidic glycoconjugates, in which the polysaccharide is obtained from Candida utilis cells and the peptides are obtained from Ricinus communis seeds. The glycoconjugates are used in the preparation of immunomodulating drugs that control the production of tumor necrosis factor (TNF).